Symrise sets out its plans

At its latest capital markets, held at its headquarters in Holzminden, Germany, Symrise presented its strategy and outlook to investors and analysts under the title ‘Unleashing the full beauty of One Symrise’. The occasion also marked the 150th anniversary of the launch of its predecessor and the first synthesis of vanillin, both in 1874. 

The company will continued to focus on its three strategic pillars of growth, efficiency and portfolio with an expanded focus on new priorities under the One Symrise strategy. These comprise optimised processes, and sustainability and digitalisation. A global transformation office has been set up to guide and support the execution of the strategic roadmap. 

“Future growth will be driven by a holistic, company-wide ecosystem for innovation,” Symrise stated. It will “accelerate cosmetic ingredients and health solutions” under the concept of ‘One Care’, while increasing its focus on efficiency across the value chain from procurement to delivery “through integrated processes at corporate level”. 

The company has slightly upgraded its organic sales growth forecast for 2024 to over 7%, because of inflation, and the EBITDA margin is now expected to be above 20%. The 2025 targets remain in place: organic sales growth of 5-7% (CAGR) with an EBITDA margin of 20-23%. Similar long-term targets remain in place to 2028.